SHANGHAI, Dec. 22 /PRNewswire-Asia/ -- WuXi PharmaTech , a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, today announced the winners of its third Life Science and Chemistry Awards, held on December 20, 2009, at the China World Hotel in Beijing.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The theme of this year’s awards was Biology in Drug Discovery. The selection panel was comprised of ten scholars with extensive industry expertise:
Sixteen winners were selected through a rigorous, objective, and transparent evaluation process that began in July.
Dr. Yongfeng Shang is a newly selected Academician of the Chinese Academy of Sciences. Dr. Baofeng Yang is a newly selected Academician of the Chinese Academy of Engineering.
“I am honored to receive the WuXi PharmaTech Life Science and Chemistry Award,” said Dr. Yongfeng Shang, the First Prize Winner. “This award recognizes my research work and inspires me to delve deeper into the study of pharmaceutical research and development. As a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, WuXi PharmaTech founded this award to encourage scientists working in pharmaceutical research and development and to promote basic scientific research and innovation related to life science and chemistry. I will continue to spare no efforts to make my contributions to the life science industry.”
Han Qide, Vice Chairman of the Standing Committee of the National People’s Congress, and Mr. Zhang Huaixi, Vice Chairman of the Tenth Chinese People’s Political Consultative Conference, attended the awards ceremony, presented the awards, and congratulated the winners, encouraging them to continue their contributions to China’s pharmaceutical research and scientific development.
“We are honored to host the third WuXi PharmaTech Life Science and Chemistry Awards Ceremony,” said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. “Without the robust talent pool of scientists available in China and the support of our society, WuXi could not have built its broad platform of research capabilities. We want to express our gratitude to everyone who supports our company and its contributions to the pharmaceutical industry of China. WuXi will continue to expand its service portfolio to transform drug research and development and ultimately to save lives and improve human health.”
CONTACT: WuXi PharmaTech (Cayman) Inc. - Ronald Aldridge (for investors),
Director of Investor Relations, +1-201-585-2048, or ir@wuxiapptec.com;
Stephanie Liu (for the media) of WuXi PharmaTech (Cayman) Inc.,
+86-21-5046-4362, or pr@wuxiapptec.com
